241 related articles for article (PubMed ID: 33086557)
1. Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis.
Dziedzic A; Miller E; Bijak M; Przyslo L; Saluk-Bijak J
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086557
[TBL] [Abstract][Full Text] [Related]
2. The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y
Dziedzic A; Miller E; Saluk-Bijak J; Niwald M; Bijak M
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207429
[TBL] [Abstract][Full Text] [Related]
3. Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation.
Zhang Y; Wang Y; Xiang Y; Lee W; Zhang Y
J Thromb Haemost; 2012 Mar; 10(3):411-8. PubMed ID: 22212092
[TBL] [Abstract][Full Text] [Related]
4. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome.
Larocca LM; Heller PG; Podda G; Pujol-Moix N; Glembotsky AC; Pecci A; Alberelli MA; Balduini CL; Landolfi R; Cattaneo M; De Candia E
Platelets; 2015; 26(8):751-7. PubMed ID: 25806575
[TBL] [Abstract][Full Text] [Related]
5. Platelet protease-activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertension.
Maeda NY; Carvalho JH; Otake AH; Mesquita SM; Bydlowski SP; Lopes AA
Thromb Res; 2010 Jan; 125(1):38-43. PubMed ID: 19447475
[TBL] [Abstract][Full Text] [Related]
6. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
[TBL] [Abstract][Full Text] [Related]
7. Platelets are activated in ANCA-associated vasculitis via thrombin-PARs pathway and can activate the alternative complement pathway.
Miao D; Li DY; Chen M; Zhao MH
Arthritis Res Ther; 2017 Nov; 19(1):252. PubMed ID: 29141676
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
9. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
10. Oligosaccharide Blocks PAR1 (Proteinase-Activated Receptor 1)-PAR4-Mediated Platelet Activation by Binding to Thrombin Exosite II and Impairs Thrombosis.
Li S; Wang W; Lin L; Yang L; Cai Y; Yang X; Zhang T; Xiao C; Yan H; Gao N; Zhao J
Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):253-266. PubMed ID: 36519467
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans.
Reiter R; Derhaschnig U; Spiel A; Keen P; Cardona F; Mayr F; Jilma B
Thromb Haemost; 2003 Nov; 90(5):898-903. PubMed ID: 14597986
[TBL] [Abstract][Full Text] [Related]
12. Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets.
French SL; Paramitha AC; Moon MJ; Dickins RA; Hamilton JR
PLoS One; 2016; 11(10):e0165565. PubMed ID: 27788223
[TBL] [Abstract][Full Text] [Related]
13. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
Lee H; Sturgeon SA; Jackson SP; Hamilton JR
Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
[TBL] [Abstract][Full Text] [Related]
14. Platelet specific promoters are insufficient to express protease activated receptor 1 (PAR1) transgene in mouse platelets.
Arachiche A; de la Fuente M; Nieman MT
PLoS One; 2014; 9(5):e97724. PubMed ID: 24830314
[TBL] [Abstract][Full Text] [Related]
15. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-Rich Microdomains Contribute to PAR1 Signaling in Platelets Despite a Weak Localization of the Receptor in These Microdomains.
Rabani V; Lagoutte-Renosi J; Series J; Valot B; Xuereb JM; Davani S
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138025
[TBL] [Abstract][Full Text] [Related]
18. [Role of adenosine diphosphate in the course of thrombin signal transmission].
Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonist.
Hawes BE; Zhai Y; Hesk D; Wirth M; Wei H; Chintala M; Seiffert D
Eur J Pharmacol; 2015 Sep; 762():221-8. PubMed ID: 26022529
[TBL] [Abstract][Full Text] [Related]
20. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
Covic L; Gresser AL; Kuliopulos A
Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
